LLY
Eli Lilly and Company
LLY has the edge over MTD overall, supported by stronger modeled upside and stronger fundamentals.
MTD
Mettler-Toledo International Inc.
MTD's outlook is improving, though it still trails on the overall score.
LLY Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Healthy |
LLY's revenue, profitability, cash flow and balance sheet are all currently healthy.
MTD Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| Healthy | |
| Healthy |
MTD's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
LLY PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 27x | $845 | -41% |
| Forward | 30x | $1,427 | — |
| Current | 46x | $1,427 | — |
| Fair | 48x | $1,466 | +2.7% |
| Expensive | 85x | $2,612 | +83% |
Historical ranges are pointers, not guarantees.
LLY's PE is in its fair range at 46x. If earnings grow as analysts expect, today's price would be 30x next year's earnings, in its cheap range.
MTD PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 31x | $1,406 | -19% |
| Forward | 34x | $1,731 | — |
| Fair | 36x | $1,655 | -4.4% |
| Current | 38x | $1,731 | — |
| Expensive | 46x | $2,122 | +23% |
Historical ranges are pointers, not guarantees.
MTD has the edge over LLY in the historical PE scenario, which offers more potential upside but is not a forecast.
LLY Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for LLY, with profitability improving.
MTD Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for MTD, with profitability improving.
LLY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $46.82 | +52% |
| Q3 2026 | $30.81 | +51% |
| Q2 2026 | $29.80 | +95% |
| Q1 2026 | $28.15 | +129% |
| Q4 2025 | $22.95 | +96% |
| Q3 2025 | $20.44 | +121% |
| Q2 2025 | $15.30 | +88% |
| Q1 2025 | $12.29 | +81% |
| Q4 2024 | $11.71 | +102% |
LLY has the edge over MTD on earnings, with stronger typical year-over-year growth.
MTD Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $51.52 | +12% |
| Q3 2026 | $46.08 | +15% |
| Q2 2026 | $44.36 | +12% |
| Q1 2026 | $42.57 | +6.3% |
| Q4 2025 | $42.05 | +3.9% |
| Q3 2025 | $40.05 | +8% |
| Q2 2025 | $39.44 | +8.5% |
| Q1 2025 | $40.05 | +12% |
| Q4 2024 | $40.48 | +13% |
MTD's earnings per share have climbed steadily: $46.08 over the past year, up 15% from the year before, and higher year over year for eight quarters in a row.
LLY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.4B | +39% |
| Q2 2026 | $23B | +48% |
| Q1 2026 | $19.8B | +56% |
| Q4 2025 | $19.3B | +43% |
| Q3 2025 | $17.6B | +54% |
| Q2 2025 | $15.6B | +38% |
| Q1 2025 | $12.7B | +45% |
| Q4 2024 | $13.5B | +45% |
LLY has the edge over MTD on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 34% | -6.6 points |
| Q2 2026 | 40% | -3.3 points |
| Q1 2026 | 45% | +18 points |
| Q4 2025 | 43% | +5.6 points |
| Q3 2025 | 41% | +27 points |
| Q2 2025 | 44% | +12 points |
| Q1 2025 | 27% | -1.8 points |
| Q4 2024 | 37% | +10 points |
LLY has the edge over MTD on profitability, with a higher operating margin.
MTD Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.1B | +6.3% |
| Q2 2026 | $1B | +4.5% |
| Q1 2026 | $947.1M | +7.2% |
| Q4 2025 | $1.1B | +8.1% |
| Q3 2025 | $1B | +7.9% |
| Q2 2025 | $983.2M | +3.9% |
| Q1 2025 | $883.7M | -4.6% |
| Q4 2024 | $1B | +12% |
MTD's revenue has grown year over year for six quarters in a row: $1.1B last quarter, up 6.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 27% | +1.3 points |
| Q2 2026 | 28% | +2.9 points |
| Q1 2026 | 22% | -0.7 points |
| Q4 2025 | 29% | -1 points |
| Q3 2025 | 26% | -1 points |
| Q2 2025 | 25% | -0.4 points |
| Q1 2025 | 23% | -1 points |
| Q4 2024 | 30% | +5.2 points |
MTD's operating margin was 27% last quarter, up 1.3 points from the same quarter a year ago.
LLY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $8.2B | +22% |
| Q2 2026 | $7.8B | +458% |
| Q1 2026 | $3B | +1826% |
| Q4 2025 | $677.9M | -31% |
| Q3 2025 | $6.7B | +186% |
| Q2 2025 | $1.4B | +476% |
| Q1 2025 | $156.1M | -13% |
| Q4 2024 | $977.8M | +$2.4B |
LLY has the edge over MTD on cash flow, with more consistent year-over-year improvement.
MTD Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $281.5M | +2.4% |
| Q2 2026 | $282.6M | +33% |
| Q1 2026 | $122.4M | -31% |
| Q4 2025 | $184.1M | -18% |
| Q3 2025 | $274.9M | +18% |
| Q2 2025 | $212.5M | -9.1% |
| Q1 2025 | $177.2M | +2.7% |
| Q4 2024 | $224.9M | -9.7% |
MTD's free cash flow has been positive every quarter for six years: $871M over the past year, down 2.1% from the year before.
LLY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -300K shares |
| 1 year | -0.6% | -5.4M shares |
| 3 years | -0.7% | -6.4M shares |
| 5 years | -1.9% | -17.4M shares |
| Available history | -4.5% | -42.3M shares |
LLY has 893M diluted shares, down 0.6% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $377M |
| Q2 2026 | $1.6B |
| Q1 2026 | $2.4B |
| Q4 2025 | $1.5B |
| Q3 2025 | $708.1M |
| Q2 2025 | $692.2M |
| Q1 2025 | $1.2B |
| Q4 2024 | $2.1B |
LLY spent $5.8B buying back its own shares over the past year, up 26% from the year before.
MTD Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.7% | -148K shares |
| 1 year | -2.7% | -552K shares |
| 3 years | -8.5% | -1.9M shares |
| 5 years | -14% | -3.4M shares |
| Available history | -19% | -4.6M shares |
MTD has the edge over LLY on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $226.2M |
| Q2 2026 | $206.3M |
| Q1 2026 | $206.3M |
| Q4 2025 | $143.7M |
| Q3 2025 | $218.7M |
| Q2 2025 | $218.7M |
| Q1 2025 | $218.7M |
| Q4 2024 | $212.5M |
MTD spent $782M buying back its own shares over the past year, down 9.9% from the year before.
LLY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.2x | Healthy |
| Q2 2026 | 1.3x | Healthy |
| Q1 2026 | 1.2x | Healthy |
| Q4 2025 | 1.3x | Healthy |
| Q3 2025 | 1.3x | Healthy |
| Q2 2025 | 2.0x | Healthy |
| Q1 2025 | 2.3x | Moderate |
| Q4 2024 | 2.1x | Moderate |
LLY has the edge over MTD on leverage, with a lower net debt burden relative to earnings.
MTD Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.6x | Healthy |
| Q2 2026 | 1.8x | Healthy |
| Q1 2026 | 1.9x | Healthy |
| Q4 2025 | 1.9x | Healthy |
| Q3 2025 | 1.9x | Healthy |
| Q2 2025 | 1.9x | Healthy |
| Q1 2025 | 1.7x | Healthy |
| Q4 2024 | 1.8x | Healthy |
MTD's net debt is about 1.6 years of its operating earnings (EBITDA), down from 1.9 years a year ago.
LLY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 68.3 | Neutral |
| Stochastic | 84.1 | Overbought |
LLY's weekly RSI is 68 (neutral) and its Stochastic is 84 (overbought).
MTD Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 73.7 | Overbought |
| Stochastic | 86.2 | Overbought |
MTD's weekly RSI is 74 (overbought) and its Stochastic is 86 (overbought).
LLY PE vs Healthcare Sector
| Metric | LLY | Sector median | Relative |
|---|---|---|---|
| PE | 46x | 26x | 79% above |
| PE % | 48 | 29 | 19 pts above |
LLY is trading at 46x earnings, a 79% premium to the Healthcare sector's median of 26x.
MTD PE vs Healthcare Sector
| Metric | MTD | Sector median | Relative |
|---|---|---|---|
| PE | 38x | 26x | 45% above |
| PE % | 58 | 29 | 29 pts above |
MTD has the edge over LLY on valuation relative to its sector.
LLY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,279.4 | 12% above |
| 20 week MA | $1,218.8 | 17% above |
| 50 week MA | $1,102.2 | 29% above |
| 100 week MA | $954.1 | 50% above |
| 200 week MA | $797.5 | 79% above |
LLY is in an uptrend: it's above all five of its weekly moving averages, and 79% above its 200-week average.
MTD Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,621.0 | 6.8% above |
| 20 week MA | $1,465.0 | 18% above |
| 50 week MA | $1,359.5 | 27% above |
| 100 week MA | $1,302.9 | 33% above |
| 200 week MA | $1,308.6 | 32% above |
MTD has climbed back above all five of its weekly moving averages, and it's now 32% above its 200-week average.
LLY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $131.5 | $166.7 | +27% |
| 2021 | $166.7 | $273.1 | +64% |
| 2022 | $273.1 | $367.9 | +35% |
| 2023 | $367.9 | $582.9 | +58% |
| 2024 | $582.9 | $783.2 | +34% |
| 2025 | $783.2 | $1,077.8 | +38% |
| 2026 YTD | $1,077.8 | $1,427.3 | +32% |
LLY has the edge over MTD on returns for 2026, with the stronger performance.
MTD Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $792.8 | $1,140.2 | +44% |
| 2021 | $1,140.2 | $1,626.2 | +43% |
| 2022 | $1,626.2 | $1,439.1 | -12% |
| 2023 | $1,439.1 | $1,213.0 | -16% |
| 2024 | $1,213.0 | $1,234.2 | +1.8% |
| 2025 | $1,234.2 | $1,420.1 | +15% |
| 2026 YTD | $1,420.1 | $1,730.9 | +22% |
MTD has finished higher in four of the last six years. It's up 22% so far in 2026.